These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 31390580)

  • 1. HIV-1 persistence in the central nervous system: viral and host determinants during antiretroviral therapy.
    Balcom EF; Roda WC; Cohen EA; Li MY; Power C
    Curr Opin Virol; 2019 Oct; 38():54-62. PubMed ID: 31390580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV pharmacology: barriers to the eradication of HIV from the CNS.
    McGee B; Smith N; Aweeka F
    HIV Clin Trials; 2006; 7(3):142-53. PubMed ID: 16880170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial Cells: The Main HIV-1 Reservoir in the Brain.
    Wallet C; De Rovere M; Van Assche J; Daouad F; De Wit S; Gautier V; Mallon PWG; Marcello A; Van Lint C; Rohr O; Schwartz C
    Front Cell Infect Microbiol; 2019; 9():362. PubMed ID: 31709195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment.
    Spudich S; González-Scarano F
    Cold Spring Harb Perspect Med; 2012 Jun; 2(6):a007120. PubMed ID: 22675662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication.
    Fois AF; Brew BJ
    Curr HIV/AIDS Rep; 2015 Jun; 12(2):299-303. PubMed ID: 25869939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Reservoirs During Suppressive Therapy.
    Barton K; Winckelmann A; Palmer S
    Trends Microbiol; 2016 May; 24(5):345-355. PubMed ID: 26875617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting and eradicating latent CNS reservoirs of HIV-1: Original strategies and new models.
    Saeb S; Wallet C; Rohr O; Schwartz C; Loustau T
    Biochem Pharmacol; 2023 Aug; 214():115679. PubMed ID: 37399950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
    Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV reservoirs: pathogenesis and obstacles to viral eradication and cure.
    Chun TW; Fauci AS
    AIDS; 2012 Jun; 26(10):1261-8. PubMed ID: 22472858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy.
    Araínga M; Edagwa B; Mosley RL; Poluektova LY; Gorantla S; Gendelman HE
    Retrovirology; 2017 Mar; 14(1):17. PubMed ID: 28279181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research.
    Churchill MJ; Cowley DJ; Wesselingh SL; Gorry PR; Gray LR
    J Neurovirol; 2015 Jun; 21(3):290-300. PubMed ID: 25060300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 persistence in the CNS: Mechanisms of latency, pathogenesis and an update on eradication strategies.
    Sonti S; Sharma AL; Tyagi M
    Virus Res; 2021 Oct; 303():198523. PubMed ID: 34314771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 replication in central nervous system increases over time on only protease inhibitor therapy.
    Donath M; Wolf T; Stürmer M; Herrmann E; Bickel M; Khaykin P; Göpel S; Gute P; Haberl A; de Leuw P; Schüttfort G; Berger A; Stephan C;
    Med Microbiol Immunol; 2016 Dec; 205(6):575-583. PubMed ID: 27469377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain.
    Asahchop EL; Meziane O; Mamik MK; Chan WF; Branton WG; Resch L; Gill MJ; Haddad E; Guimond JV; Wainberg MA; Baker GB; Cohen EA; Power C
    Retrovirology; 2017 Oct; 14(1):47. PubMed ID: 29037245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host and Viral Factors Influencing Interplay between the Macrophage and HIV-1.
    Machado Andrade V; Stevenson M
    J Neuroimmune Pharmacol; 2019 Mar; 14(1):33-43. PubMed ID: 29995208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combating the HIV reservoirs.
    van Marle G; Church DL; van der Meer F; Gill MJ
    Biotechnol Genet Eng Rev; 2018 Apr; 34(1):76-89. PubMed ID: 29781356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Suppression of HIV in Myeloid Cells by the BRD4-Selective Small Molecule Modulator ZL0580.
    Alamer E; Zhong C; Liu Z; Niu Q; Long F; Guo L; Gelman BB; Soong L; Zhou J; Hu H
    J Virol; 2020 May; 94(11):. PubMed ID: 32188727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs.
    Coiras M; López-Huertas MR; Pérez-Olmeda M; Alcamí J
    Nat Rev Microbiol; 2009 Nov; 7(11):798-812. PubMed ID: 19834480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation of HIV-1 persistence and evolving strategies for virus eradication.
    Dhamija N; Rawat P; Mitra D
    Subcell Biochem; 2013; 61():479-505. PubMed ID: 23150264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.